Inhibition by streptococcal immunopotentiator OK432 of lymph-node metastasis in hamster cheek-pouch carcinoma with enhancement of tumour necrosis factor-α and interleukin-6 in serum

Archives of Oral Biology - Tập 41 - Trang 513-516 - 1996
Junko Nakajima1, Makio Mogi2, Takehiro Chino1
1Department of Oral and Maxillofacial Surgery I, Matsumoto Dental College, Shiojiri, Nagano, 399-07, Japan
2Oral Biochemistry, Matsumoto Dental College, Shiojiri, Nagano, 399-07, Japan

Tài liệu tham khảo

Beutler, 1986, Cachectin and tumour necrosis factor as two sides of the same biological coin, Nature, 320, 584, 10.1038/320584a0 Blick, 1987, Phase I study of recombinant tumor necrosis factor in cancer patients, Cancer Res., 47, 2986 Christmas, 1986, Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432, Int. J. Immunopharmacol., 8, 83, 10.1016/0192-0561(86)90076-7 Colotta, 1983, Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells, Br. J. Cancer, 48, 515, 10.1038/bjc.1983.224 Farrar, 1982, The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses, Immunol. Rev., 63, 129, 10.1111/j.1600-065X.1982.tb00414.x Fukui, 1987, Antitumor activity of a streptococcus pyogenes preparation (OK-432). II. Analysis of the cytotoxic lymphocytes induced by OK-432 injection into tumor-bearing F344 rats, J. natn. Cancer Inst., 79, 1019 Fukui, 1989, Production of interleukin 6 by human spleen cells stimulated with streptococcal preparation OK-432, Immunol. Lett., 21, 127, 10.1016/0165-2478(89)90048-5 Grunfeld, 1990, Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities, Adv. intern. Med., 35, 45 Hanna, 1972, Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. 2. Comparative effects of vaccinia virus, oxazolone, a and turpentine, J. natn. Cancer Inst., 48, 1697 Hanna, 1982, Role of natural killer cells in control of cancer metastasis, Cancer Metastasis Rev., 1, 45, 10.1007/BF00049480 Ichimura, 1984, Characterization of mouse natural killer cell activating factor (NKAF) induced by OK-432: evidence for interferon- and interleukin 2-independent NK cell activation, Br. J. Cancer, 50, 97, 10.1038/bjc.1984.144 Kage, 1987, Regional lymph node metastasis created by partial excision of carcinomas induced in hamster cheek pouch with 9,10-dimethyl-1,2-benzanthracene, J. dent. Res., 66, 1673, 10.1177/00220345870660111401 Kage, 1988, Lung and cervical lymph-node metastasis after cortisone enhancement in hamster cheek-pouch carcinogenesis, Archs oral Biol., 33, 459, 10.1016/0003-9969(88)90205-1 Lu, 1992, Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression, 89, 9215 Mogi, 1984, Detection of inactive or less active forms of tyrosine hydroxylase in human adrenals by a sandwich enzyme immunoassay, Analyt. Biochem., 138, 125, 10.1016/0003-2697(84)90779-6 Mogi, 1994, Tumor necrosis factor-α increases both in the brain and in the cerebrospinal fluid from parkinsonian patients, Neurosci. Lett., 165, 208, 10.1016/0304-3940(94)90746-3 Mogi, 1994, Increased β2-microglobulin in both parotid and submadibular-sublingual saliva from patients with Sjogren's syndrome, Archs oral Biol., 39, 913, 10.1016/0003-9969(94)90024-8 Mullen, 1992, Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential, Cancer Res., 52, 6020 Nakajima, 1995, Hypertriglyceridemia associated with tumor necrosis factor-α in hamster cheek pouch carcinogenesis, J. dent. Res., 10.1177/00220345950740090901 Noda, 1986, Interferon-gamma induction in human peripheral blood mononuclear cells by OK-432, a killed preparation of streptococcus pyogenes, Microbiol. Immunol., 30, 81, 10.1111/j.1348-0421.1986.tb00923.x Oshimi, 1980, Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432, J. natn. Cancer Inst., 65, 1265 Sato, 1984, Effects of intradermal administration of streptococcal preparation OK-432 on interferon and natural killer cell activities in patients with oral cancer, Int. J. oral Surg., 13, 7, 10.1016/S0300-9785(84)80050-2 Takai, 1988, B-cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes, J. Immunol., 140, 508, 10.4049/jimmunol.140.2.508 Uchida, 1983, Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432, J. natn. Cancer Inst., 71, 673 Vanky, 1986, Lysis of autologous tumor cells by high-density lymphocytes is potentiated by the streptococcal preparations OK432 (Picibanil), Int. J. Cancer, 37, 531, 10.1002/ijc.2910370410 Yamada, 1988, Serum sialic acid alterations in the hamster cheek pouch carcinogenesis, Jap. J. oral Biol., 30, 695, 10.2330/joralbiosci1965.30.695 Yamada, 1992, Enhancement by cyclosporin A of metastasis from hamster cheek pouch carcinogenesis, Archs oral Biol., 37, 593, 10.1016/0003-9969(92)90143-V Yamamoto, 1986, Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation, Immunopharmacology, 11, 79, 10.1016/0162-3109(86)90027-5 Watanabe, 1985, Inhibitory effect of tumor necrosis serum on the metastasis of B-16 mouse melanoma cells, Jpn. J. Cancer Res., 76, 989 Zhang, 1986, Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2, Cancer Immunol. Immunother., 21, 19, 10.1007/BF00199372